Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study by Takuya Yagi, Michio Kanekiyo, Junichi Ito, Ryoko Ihara, Kazushi Suzuki, Atsushi Iwata, Takeshi Iwatsubo, Ken Aoshima, Alzheimer's Disease Neuroimaging Initiative, Japanese Alzheimer's Disease Neuroimaging Initiative

Get full text

Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease–related cognitive decline by Yuan Shang, Georgina Torrandell‐Haro, Francesca Vitali, Roberta Diaz Brinton, The Alzheimer's Disease Neuroimaging Initiative (ADNI)

Get full text

Machine learning–enhanced screening funnel for clinical trials in Alzheimer's disease by Scott Gladstein, Liuqing Yang, Dustin Wooten, Xin Huang, Robert Comley, Qi Guo, the Alzheimer's Disease Neuroimaging Initiative

Get full text

The relative efficiency of time‐to‐progression and continuous measures of cognition in presymptomatic Alzheimer's disease by Dan Li, Samuel Iddi, Paul S. Aisen, Wesley K. Thompson, Michael C. Donohue, Alzheimer's Disease Neuroimaging Initiative

Get full text

Marital dissolution and cognition: The mediating effect of Aβ neuropathology by Avinash Chandra, Rifah Anjum, Sheena Waters, Petroula Proitsi, Laura J. Smith, Charles R. Marshall, for the Alzheimer's Disease Neuroimaging Initiative

Get full text

Accurate and robust prediction of Amyloid-β brain deposition from plasma biomarkers and clinical information using machine learning by Jiayuan Xu, Andrew J. Doig, Sofia Michopoulou, Sofia Michopoulou, Petroula Proitsi, Petroula Proitsi, Fumie Costen, The Alzheimer's disease neuroimaging initiative

Get full text

A longitudinal study of functional brain complexity in progressive Alzheimer's disease by Ru Zhang, Leon Aksman, Dilmini Wijesinghe, John M. Ringman, Danny J. J. Wang, Kay Jann, for the Alzheimer's Disease Neuroimaging Initiative

Get full text

Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease. by Christiane Reitz, Giuseppe Tosto, Richard Mayeux, Jose A Luchsinger, NIA-LOAD/NCRAD Family Study Group, Alzheimer's Disease Neuroimaging Initiative

Get full text

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease by Niklas Mattsson, Philip S Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow, Oskar Hansson, the Alzheimer's Disease Neuroimaging Initiative

Get full text

Therapeutic time window of disease‐modifying therapy for early Alzheimer's disease by Saki Nakashima, Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Kazushi Suzuki, Atsushi Iwata, Tatsushi Toda, Takeshi Iwatsubo, for Alzheimer's Disease Neuroimaging Initiative

Get full text

Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts by Tamao Tsukie, Kensaku Kasuga, Masataka Kikuchi, Takanobu Ishiguro, Akinori Miyashita, Osamu Onodera, Takeshi Iwatsubo, Japanese Alzheimer's Disease Neuroimaging Initiative, Takeshi Ikeuchi

Get full text

Journey to the other side of the brain: asymmetry in patients with chronic mild or moderate traumatic brain injury by David E Ross, John D Seabaugh, Jan M Seabaugh, Claudia Alvarez, Laura Peyton Ellis, Christopher Powell, Christopher Reese, Leah Cooper, Katherine Shepherd, for the Alzheimer's Disease Neuroimaging Initiative

Get full text

Institutionalization risk and costs associated with agitation in Alzheimer's disease by Martin Cloutier, Marjolaine Gauthier‐Loiselle, Patrick Gagnon‐Sanschagrin, Annie Guerin, Ann Hartry, Ross A. Baker, Ruth Duffy, Keva Gwin, Myrlene Sanon Aigbogun, Alzheimer's Disease Neuroimaging Initiative

Get full text

Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression? by Krista Lanctot, Linus Jönsson, Alireza Atri, Russ Paulsen, Soeren Mattke, Julie Hviid Hahn‐Pedersen, Pepa Polavieja, Thomas Maltesen, Teresa León, Anders Gustavsson, Alzheimer's Disease Neuroimaging Initiative

Get full text

Journey to the other side of the brain: asymmetry in patients with chronic mild or moderate traumatic brain injury by David E Ross, John D Seabaugh, Jan M Seabaugh, Claudia Alvarez, Laura Peyton Ellis, Christopher Powell, Christopher Reese, Leah Cooper, Katherine Shepherd, for the Alzheimer's Disease Neuroimaging Initiative

Get full text

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease by Davina Biel, Marc Suárez‐Calvet, Paul Hager, Anna Rubinski, Anna Dewenter, Anna Steward, Sebastian Roemer, Michael Ewers, Christian Haass, Matthias Brendel, Nicolai Franzmeier, for the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Get full text

Impact of sleep disruptions on gray matter structural covariance networks across the Alzheimer's disease continuum by Xiao Luo, Kaicheng Li, Qingze Zeng, Xiaocao Liu, Jixuan Li, Xinyi Zhang, Siyan Zhong, Lingyun Liu, Shuyue Wang, Chao Wang, Yanxing Chen, Minming Zhang, Peiyu Huang, for the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Get full text

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. by Sid E O'Bryant, Guanghua Xiao, Robert Barber, Ryan Huebinger, Kirk Wilhelmsen, Melissa Edwards, Neill Graff-Radford, Rachelle Doody, Ramon Diaz-Arrastia, Texas Alzheimer's Research & Care Consortium, Alzheimer's Disease Neuroimaging Initiative

Get full text

Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition by Corey J. Bolton, Marilyn Steinbach, Omair A. Khan, Dandan Liu, Julia O'Malley, Logan Dumitrescu, Amalia Peterson, Angela L. Jefferson, Timothy J. Hohman, Henrik Zetterberg, Katherine A. Gifford, for the Alzheimer's Disease Neuroimaging Initiative

Get full text

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers by Rik Ossenkoppele, Juhan Reimand, Ruben Smith, Antoine Leuzy, Olof Strandberg, Sebastian Palmqvist, Erik Stomrud, Henrik Zetterberg, the Alzheimer's Disease Neuroimaging Initiative, Philip Scheltens, Jeffrey L Dage, Femke Bouwman, Kaj Blennow, Niklas Mattsson‐Carlgren, Shorena Janelidze, Oskar Hansson

Get full text